10 Reviews
Latest technology to learn Good leaning curve Friendly team and knowledgeable
Too much micro management No much diversity High work load Less compensation Expected to work on weekends
Acrivon Therapeutics has filed to raise $119 million in an IPO, although the final figure may differ. Click here to learn more about ACRV IPO.
Halliburton (NYSE:HAL - Get Rating) was the target of a significant increase in short interest in the month of September. As of September 30th, there was short interest totalling 18,610,000 shares, an increase of 5.1% from the September 15th total of 17,710,000 shares. Based on an average trading v…
US$ 140,000
Median Total Comp
25TH%
70TH%
90TH%